Vanderbilt Research Trending Archives
Amount of daylight may impact serotonin programming
Jan. 19, 2017—The duration of exposure to daylight, or the “photoperiod,” may affect development of seasonal affective disorder by programming serotonin neurons in the brain, according to Vanderbilt University researchers.
Research that ruled in 2016: Readers’ favorite stories
Dec. 16, 2016—Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
2016 a year of milestones, accomplishments for VUMC
Dec. 15, 2016—The following is a roundup of the news that made headlines at Vanderbilt University Medical Center in 2016.
Blood-brain barrier on a chip sheds new light on “silent killer”
Dec. 6, 2016—A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.
Bioluminescent sensor causes brain cells to glow in the dark
Oct. 27, 2016—A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.
Study may help predict anxiety risk in children
Oct. 13, 2016—In what could be a way to predict which children might be vulnerable to anxiety disorders, a Vanderbilt study has shown that an altered prefrontal cortex function in the brain marks a heightened anxiety risk in children.
Antidepressants’ heart impact less than expected: study
Oct. 13, 2016—A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks.
Vanderbilt scientists to lead chronic disease research initiative in Vietnam
Oct. 6, 2016—Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.
Researchers eye potential schizophrenia ‘switch’
Sep. 15, 2016—Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.
Study reveals new clues to cystic fibrosis ‘gender gap’
Sep. 15, 2016—A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”
VICC leaders active in new Cancer Moonshot recommendations
Sep. 9, 2016—As part of the national Cancer Moonshot initiative, a Blue Ribbon Panel (BRP) of cancer leaders, including four from Vanderbilt-Ingram Cancer Center, has delivered a series of recommendations to accelerate the pace of cancer prevention efforts and scientific discovery.
Trial to test whether DBS slows Parkinson’s progression
Sep. 1, 2016—A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients.
